분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2018-10-04 11:25:53 , Hit : 357
 Frances H. Arnold, George P. Smith, and Gregory P. Winter share 2018 Nobel Prize in Chemistry

https://cen.acs.org/biological-chemistry/Frances-H-Arnold-George-P-Smith-and-Gregory-P-Winter-share-2018-Nobel-Prize-in-Chemistry/96/web/2018/10?utm_source=NonMember&utm_medium=Newsletter&utm_campaign=CEN

Trio recognized for harnessing evolution to identify new enzymes and binding proteins

by  Celia Henry Arnaud  


October 3, 2018


he 2018 Nobel Prize in Chemistry was awarded to Frances H. Arnold of California Institute of Technology for the directed evolution of enzymes and to George P. Smith of the University of Missouri and Gregory P. Winter of the MRC Laboratory of Molecular Biology for the phage display of peptides and antibodies. Arnold will receive half of the approximately $1 million prize; Smith and Winter will split the other half equally.


This year’s prize “recognizes the power of harnessing protein evolution to solve a wide range of problems in the molecular sciences,” says David R. Liu of Harvard University, who has developed a version of directed evolution called phage-assisted directed evolution. “My hat’s off to Smith, Winter, and Arnold for their contributions to this multidisciplinary field that beautifully integrates chemistry, molecular biology, and protein science.”


Directed evolution is an iterative lab method involving mutation and screening that speeds up the natural selection process through which life on Earth evolved. In Arnold’s technique, she introduces random mutations into the gene for a starting enzyme, expresses the variant genes in bacteria, and screens the mutated enzymes produced by the microbes for desired activity. By repeating this process with the best performers, researchers can find proteins with the desired enzymatic properties in terms of activity, binding affinity, or specificity.


Arnold conducted the first directed evolution of enzymes in 1993. In that work, she evolved a version of the enzyme subtilisin E that was active at high concentrations of the polar organic solvent dimethylformamide. Four rounds of mutagenesis and screening resulted in an enzyme that was 256 times as active as the original enzyme.




Sign up for C&EN's must-read weekly newsletter



      
  
Subscribe »



Contact us  to opt out anytime
  
  

Smith reported the original phage display method in 1985. In this library-based method for screening for proteins that bind a specific molecule, the gene for each member of the library is inserted in the DNA for coat protein III of phage, a virus that infects bacteria. The phage infects and reproduces in bacteria. Scientists can then use the target molecule as bait to enrich phages released by the bacteria that have the binding protein of interest on their surface.


Sequencing the genetic material of the collected phages yields genes for proteins with desired binding affinity.


Winter extended phage display to screening for novel antibodies. In 1990, Winter’s team reported the phage display of a folded and fully functional antibody fragment called a single-chain variable fragment. This first demonstration identified selective antibodies that could bind hen egg-white lysozyme but not human lysozyme or turkey egg-white lysozyme.


Directed evolution and phage display have both become widely used methods. C&EN featured Provivi, a company founded by Arnold and two of her coworkers, in its 10 Start-ups to Watch in 2015. Provivi uses enzymes developed through directed evolution to make insect pheromones for pest control. And researchers have used phage display to identify antibodies with high binding affinity for use as pharmaceuticals. The first approved drug developed using phage display is Abbvie’s Humira (adalimumab), which was approved by the U.S. Food & Drug Administration in 2002.




Advertisement




“This is a fantastic award that recognizes how laboratory evolution, in a few short decades, has revolutionized our ability to tailor the properties of biomolecules for applications unimagined in nature,” says Donald Hilvert, an expert in directed evolution at the Swiss Federal Institute of Technology, Zurich.


Commenting on the biological flavor of this year’s chemistry Nobel, Peter K. Dorhout, president of the American Chemical Society, says, “This is chemistry. Chemistry is broad and deep. In the case of evolved enzymes, it’s catalytic chemistry and organic chemistry. To develop and understand the critical tools to evaluate how cells behave is also fundamental analytical chemistry.”







1067   Foamy 바이러스 벡터를 이용한 유전자 치료  이성욱 2008/02/12 5778
1066   Foot-and-mouth culls could be cut  이성욱 2011/05/11 3155
1065   Former Reginans changing the future of HIV  이성욱 2011/12/28 2256
1064   Fragile X syndrome: Trigger for most common form of intellectual disability and autism uncovered  이성욱 2014/03/05 1770
  Frances H. Arnold, George P. Smith, and Gregory P. Winter share 2018 Nobel Prize in Chemistry  이성욱 2018/10/04 357
1062   Friends connect on a genetic level  이성욱 2011/01/24 2262
1061   From Startups to Moguls] CRISPR 유전자가위 없이 편집한다? Homology Medicines  이성욱 2017/09/11 605
1060   Gene Editing Treats Blood Disease  이성욱 2011/07/16 3017
1059   Gene Study Based on RNA Interference May Lead to New Liver Cancer Therapies  이성욱 2017/08/14 810
1058   Gene Therapy Allows Beethoven Mouse to Hear  이성욱 2015/07/10 875
1057   Gene Therapy Appears to Help Patient With Anemia  이성욱 2010/09/17 2908
1056   Gene therapy drug approval granted to GSK  이성욱 2016/05/30 935
1055   Gene Therapy Ever More Common for Rare Disorders  이성욱 2018/05/30 333
1054   Gene Therapy for Controlling HIV Shows Early Promise  이성욱 2014/03/08 1599
1053   Gene Therapy for Immune Disorder Lasts Nine Years, Two New Studies Show  이성욱 2011/08/25 2478
1052   Gene Therapy May Thwart HIV  이성욱 2011/09/23 2055
1051   Gene therapy offers hope for Parkinson's disease  이성욱 2011/03/23 2352
1050   Gene Therapy Shows Promise Against Age-Related Macular Degeneration  이성욱 2011/05/04 2542
1049   Gene Therapy Shows Promise as Hemophilia Treatment in Animal Studies  이성욱 2011/11/10 2434
1048   Gene therapy trial on hold  이성욱 2007/08/07 4978

[이전 10개] [1].. 11 [12][13][14][15][16][17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN